Recombinant bone morphogenetic protein-2 attenuates colorectal cancer progression by orchestrating Hippo pathway activation, Yes-associated protein inhibition, and epithelial--mesenchymal transition suppression. - Wu, Yanling; Lee, Na-Ri; Liu, Yu Chuan; Kim, Min Sun; Hwang, Seongwon; Kim, Bumseok; Lee, Kwang-Bok; Kim, Soo Mi (Korean Journal of Physiology & Pharmacology, 2026)